Millions Logo
home>US Stocks>PaySign
PAYS
PaySignTechnology
$9.48+$4.32 (+83.62%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $3.0852 Week High: $16.15

PaySign Share Price Today

PaySign opened lower at $9.41, compared with its previous close of $9.48. In the last trading session, the stock traded between $9.16 and $9.96. It showed a sideways intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in PaySign is now worth

$ 426.80

Giving a profit of

$ 326.80 (326.80%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 5 Analysts

Buy
80%
Hold
20%
Sell
0%

Markets Today

Today's Change

$-0.01 (-0.05%)

Day High

$9.96

Day Low

$9.16

Day Open

$9.41

Prev Close

$9.48

Volume

16,74,780

1W Return

-38.05%

1M Return

-37.58%

3M Return

-25.05%

6M Return

41.42%

1Y Return

83.62%

Fundamentals

Market Cap ($ Mn)

539

PE Ratio

47.70

PB Ratio

12.08

PEG Ratio

27.17

ROE

18.31%

ROCE

14.71%

EPS (TTM)

$0.12

Investment Returns

1 Week

-38.05%

1 Month

-37.58%

3 Months

-25.05%

6 Months

41.42%

9 Months

179.50%

Financials

Quarterly
All values in $ Mn
19.1

Jun 25
21.6

Sep 25
22.8

Dec 25
28.0

Mar 26
28.3

Jun 26
30.8

Sep 26

Updates

12Nov

Maxim Group downgrades PaySign to Hold from Buy

Maxim Group analyst Michael Diana downgraded PaySign. Rating changed from Buy to Hold. No specific financial metrics or reasons cited in source.

Yesterday
10Nov

PaySign Q3FY26 Results: Revenue up 43% YoY, EPS guidance raised

PaySign reported record Q3FY26 revenue of $30.8 million, up 43% YoY. Net income surged over 200% to $6.7 million, or $0.11 per diluted share. FY26 GAAP EPS guidance raised to $0.37-$0.38, beating consensus of $0.34. Patient affordability revenue doubled to $16.6 million, driving margin expansion. Plasma segment faces loss of 113 centers, impacting Q4 revenue by $1.5 million.

3 days ago
14Oct

Paysign Q3FY26 Results: Earnings call scheduled for November 9, 2026

Paysign Inc. will discuss Q3FY26 results on November 9, 2026. Conference call starts at 5:00 pm Eastern time. Analysts must register by November 6 to ask questions. Replay available until January 25, 2027.

1mo ago
18Aug

Paysign to present at Midwest IDEAS Investor Conference in Chicago

Paysign, Inc. (NASDAQ: PAYS) will attend the 17th Annual Midwest IDEAS Investor Conference in Chicago this August. CEO Mark Newcomer and CFO Jeff Baker will meet with institutional investors.

2mo ago
6Aug

Paysign raises FY26 revenue and EPS guidance above estimates

Paysign Inc. upgraded its full-year 2026 financial guidance, raising revenue projections to $114.0 million–$117.0 million and GAAP EPS to $0.35–$0.37, surpassing analyst estimates of $108.552 million and $0.24. The revision follows a record Q2 with 48% revenue growth, driven by an 89% surge in pharma segment sales.

3mo ago
15Jul

Paysign to host second quarter 2026 earnings call

Paysign, Inc. announced it will host a conference call to discuss second quarter 2026 earnings on August 5, 2026, at 5:00 p.m. Eastern time. The company provided dial-in and webcast details for live access and a replay available until November 4, 2026. Financial professionals must register by July 31, 2026, to participate in the Q&A session.

4mo ago

Similar Stocks

StockLTPChange %Market CapPE
$521.13-2.26%$38,69,975.87M28.61
$172.40+2.12%$3,97,675.94M160.64
$128.38+8.82%$3,88,187.23M25.87
$234.10+0.15%$2,87,592.79M28.43
$334.47+2.49%$2,73,854.67M323.12
$248.22+1.51%$2,34,597.93M20.94
$229.06+1.46%$2,34,542.55M3,970.91
$149.26+1.81%$1,80,374.29M103.31
$218.01+2.12%$1,79,422.23M23.42
$253.66-1.88%$1,49,846.35M15.14
$70.68+0.90%$1,44,321.35M17.29
$306.36+0.30%$1,20,938.37M26.28